Abstract
‘Shenmai’ injection is derived from traditional Chinese medicine ‘Shenmaisan’ and made from Radix ginseng Rubra and Radix Ophiopogonis. Ginsenoside-Rg1, as a major constituent of Radix ginseng Rubra, is considered responsible for the efficacy of this injection. A rapid, simple and accurate method has been established for determination of ginsenoside-Rg1 in Shenmai injection and human plasma using LC-ESI-MS/MS, and to study the pharmacokinetics of Rg1 in ten healthy volunteers after intravenous single dosing of 60 mL of Shenmai injection. Following solid-phase extraction (SPE), samples were separated on a C18 column coupled with electrospray ionization mass spectrometry. The protonated analyte was quantified by multiple reaction monitoring (MRM) with a quadruple mass spectrometer in positive mode. Linearity was confirmed in the concentration range of 1 to 1000 ng/mL for Rg1, and the lower limit of quantification (LLOQ, S/N > 10) was 1 ng/mL. The intraday and interday RSDs were within 15% and mean extraction recoveries ranged from 98.6% to 104.9%. The pharmacokinetics of Rg1 in healthy volunteers conforms to the two-compartment open model. The main pharmacokinetics parameters were as follows: t1/2β, 2.09 ± 1.89 h; CL, 0.03 ± 0.01 L kg−1 h−1; AUC (0 ∼ ∞), 124.4 ± 35.9 2 ng mL−1 h and AUC (0 ∼ ∞), 127.9 ± 37.2 ng mL−1 h, respectively. Copyright © 2008 John Wiley & Sons, Ltd.

This publication has 15 references indexed in Scilit: